GLP-1s have dominated discussions in 2024 among those exploring weight-loss treatments. However, Zealand Pharma A/S (CPH: ZEAL), a Danish biotechnology firm, is already developing what it calls the “next generation” of anti-obesity therapy, aiming to outperform industry leaders like Eli Lilly and Novo Nordisk in the long term. Zealand Pharma…
SoundHound AI Inc. (NASDAQ: SOUN) has disappointed its shareholders over the past six months, and there is little indication…
The NFT (non-fungible token) auction market has cooled down significantly from its 2021 frenzy, characterized by fewer auctions and…
Brazil is on the verge of significant economic reform as the government explores a potential tax on millionaires to…
Cerebras Systems Inc. – a California-based artificial intelligence company is seeking to go public in the US at a…
In a significant shift to address South Korea’s lagging economy, the Bank of Korea has reduced its benchmark interest…
Elon Musk, CEO of Tesla Inc., showcased the highly anticipated Cybercab, an autonomous robotaxi, during an event in Burbank,…
Indian equity benchmarks opened in the red on Friday, tracking overnight losses in Wall Street. US stocks closed lower…
The 2024 hurricane season is underway, and experts are forecasting that it will be severe, as the frequency and…